in

Senator slams GlaxoSmithKline over pricey inhaler for children

Senator slams GlaxoSmithKline over pricey inhaler for children
Announcement


Pharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a key senator charged Wednesday, in the latest effort by Democrats to pressure drug companies on the issue.

Announcement
Announcement

Less than two months after GlaxoSmithKline pledged to cap out-of-pocket costs for its inhalers at $35 a month, Sen. Maggie Hassan (D-N.H.) is accusing the company of circumventing that vow through a preexisting licensing deal. That agreement discontinued a popular inhaler and replaced it with a more costly generic alternative not covered by most insurance companies.

Announcement



Source link

Announcement

What do you think?

Written by Politixia

Announcement
Announcement

Leave a Reply

Your email address will not be published. Required fields are marked *

Announcement
Claudine Gay Resigns From Harvard:Why Black Excellence Is Never Enough

Claudine Gay Resigns From Harvard:Why Black Excellence Is Never Enough

10-year-old boy woke to find family slain in Oklahoma murder-suicide that left 5 dead

10-year-old boy woke to find family slain in Oklahoma murder-suicide that left 5 dead